NM_001918.5:c.1210-4delA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001918.5(DBT):​c.1210-4delA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0252 in 1,367,896 control chromosomes in the GnomAD database, including 29 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 30)
Exomes 𝑓: 0.028 ( 27 hom. )

Consequence

DBT
NM_001918.5 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.564

Publications

2 publications found
Variant links:
Genes affected
DBT (HGNC:2698): (dihydrolipoamide branched chain transacylase E2) The branched-chain alpha-keto acid dehydrogenase complex (BCKD) is an inner-mitochondrial enzyme complex involved in the breakdown of the branched-chain amino acids isoleucine, leucine, and valine. The BCKD complex is thought to be composed of a core of 24 transacylase (E2) subunits, and associated decarboxylase (E1), dehydrogenase (E3), and regulatory subunits. This gene encodes the transacylase (E2) subunit. Mutations in this gene result in maple syrup urine disease, type 2. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
DBT Gene-Disease associations (from GenCC):
  • maple syrup urine disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • maple syrup urine disease type 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P, Myriad Women’s Health
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-100206304-AT-A is Benign according to our data. Variant chr1-100206304-AT-A is described in ClinVar as Benign. ClinVar VariationId is 166981.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0031 (461/148752) while in subpopulation AFR AF = 0.00849 (343/40380). AF 95% confidence interval is 0.00775. There are 2 homozygotes in GnomAd4. There are 244 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001918.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DBT
NM_001918.5
MANE Select
c.1210-4delA
splice_region intron
N/ANP_001909.4P11182
DBT
NM_001399969.1
c.667-4delA
splice_region intron
N/ANP_001386898.1A0A7P0T9W1
DBT
NM_001399972.1
c.667-4delA
splice_region intron
N/ANP_001386901.1A0A7P0T9W1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DBT
ENST00000370132.8
TSL:1 MANE Select
c.1210-4delA
splice_region intron
N/AENSP00000359151.3P11182
DBT
ENST00000681617.1
c.1336-4delA
splice_region intron
N/AENSP00000505544.1A0A7P0Z494
DBT
ENST00000875462.1
c.1210-4delA
splice_region intron
N/AENSP00000545521.1

Frequencies

GnomAD3 genomes
AF:
0.00309
AC:
459
AN:
148654
Hom.:
2
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00847
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00263
Gnomad ASJ
AF:
0.000583
Gnomad EAS
AF:
0.000584
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00645
Gnomad NFE
AF:
0.000640
Gnomad OTH
AF:
0.00146
GnomAD2 exomes
AF:
0.0311
AC:
6078
AN:
195454
AF XY:
0.0314
show subpopulations
Gnomad AFR exome
AF:
0.0116
Gnomad AMR exome
AF:
0.0547
Gnomad ASJ exome
AF:
0.0221
Gnomad EAS exome
AF:
0.0119
Gnomad FIN exome
AF:
0.0302
Gnomad NFE exome
AF:
0.0339
Gnomad OTH exome
AF:
0.0293
GnomAD4 exome
AF:
0.0279
AC:
33971
AN:
1219144
Hom.:
27
Cov.:
29
AF XY:
0.0271
AC XY:
16463
AN XY:
607688
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0120
AC:
378
AN:
31516
American (AMR)
AF:
0.0422
AC:
1554
AN:
36822
Ashkenazi Jewish (ASJ)
AF:
0.0224
AC:
495
AN:
22100
East Asian (EAS)
AF:
0.0149
AC:
515
AN:
34560
South Asian (SAS)
AF:
0.0211
AC:
1571
AN:
74442
European-Finnish (FIN)
AF:
0.0280
AC:
1230
AN:
43930
Middle Eastern (MID)
AF:
0.0131
AC:
68
AN:
5186
European-Non Finnish (NFE)
AF:
0.0291
AC:
26807
AN:
919790
Other (OTH)
AF:
0.0266
AC:
1353
AN:
50798
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.262
Heterozygous variant carriers
0
4204
8408
12612
16816
21020
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1044
2088
3132
4176
5220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00310
AC:
461
AN:
148752
Hom.:
2
Cov.:
30
AF XY:
0.00336
AC XY:
244
AN XY:
72526
show subpopulations
African (AFR)
AF:
0.00849
AC:
343
AN:
40380
American (AMR)
AF:
0.00262
AC:
39
AN:
14870
Ashkenazi Jewish (ASJ)
AF:
0.000583
AC:
2
AN:
3428
East Asian (EAS)
AF:
0.000585
AC:
3
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4706
European-Finnish (FIN)
AF:
0.00264
AC:
26
AN:
9836
Middle Eastern (MID)
AF:
0.00694
AC:
2
AN:
288
European-Non Finnish (NFE)
AF:
0.000640
AC:
43
AN:
67148
Other (OTH)
AF:
0.00145
AC:
3
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0241
Hom.:
5

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Maple syrup urine disease (3)
-
-
2
not specified (2)
-
-
1
Maple syrup urine disease type 1A (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.56
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201117345; hg19: chr1-100671860; COSMIC: COSV64494912; COSMIC: COSV64494912; API